OMF - Robert Thompson, 54, lung cancer, Fitchburg with Dr. Christopher Lathan, Faculty Director for Cancer Care Equity and thoracic oncologist, Dana-Farber 8-21-18
Robert was lifting weights at his local YMCA before a routine doctor’s appointment revealed he had stage 4 lung cancer.
Robert’s doctor estimated he only had one year to live. Following nine months of chemo- radiation, Robert’s cancer went into remission. However, after only one month the cancer returned.
Although a native of Alabama, Robert’s wife and her family are from New England and recommended Robert seek treatment at Dana-Farber
Since then, Robert has been under the care of Dr. Chris Lathan and his team.
Robert started in an immunotherapy clinical that lasted for two years. He was removed from the trial in May 2018 due to the cancer’s progression and is not being treated with Alimta. His scans have shown positive momentum.
Throughout his treatment Robert thanks his wife, who has been there for him throughout it all.
Dr. Christopher Lathan is an oncologist who specializes in cancers of the chest, including lung cancer.
He sees patients and has published many research papers, mainly on cancer disparities for minorities.
As Faculty Director for the Cancer Care Equity program at Dana-Farber, Dr. Lathan is committed to providing better access to cancer care and education to Boston communities.